SUNNYVALE, Calif., Sept. 19, 2018 /PRNewswire/ -- Cepheid today announced the CE-IVD marking of Xpert HCV VL Fingerstick,
"Over the past few years, Cepheid, with its collaborators at the Kirby Institute and FIND have been able to demonstrate that a rapid and accurate test for active HCV infection can be performed on a drop of blood," said David H. Persing, M.D., Ph.D., Cepheid's Chief Medical and Technology Officer. "This is the first HCV RNA detection technology sensitive enough for both active case finding and use as a potential test of cure at the point of care."
Cepheid's Xpert HCV VL Fingerstick test allows for a simplified diagnostic pathway. From blood collected into a capillary tube via fingerstick, the simple to use test detects and quantifies a wide range of HCV genotypes within 58 minutes. This enables diagnosis of HCV and initiation of direct acting antiviral treatment within a single clinic visit2, and with this, the potential for curing more people with HCV.
The new test is now available in the EU and all countries recognizing the CE-mark.
About CepheidBased in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.
1. Grebely et al. Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis. Expert Rev Mol Diagn. 2017 Dec;17(12):1109-1115. doi: 10.1080/14737159.2017.1400385. Epub 2017 Nov 8.2. Lamoury et al. Evaluation of the Xpert HCV Viral Load Fingerstick point of care assay. J Infect Dis. 2018 May 25;217(12):1889-1896. doi: 10.1093/infdis/jiy114.
For Cepheid Media Inquiries: Darwa Peterson firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/cepheid-receives-ce-ivd-clearance-for-xpert-hcv-vl-fingerstick-300715179.html
Subscribe to our Free Newsletters!